Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuh-Pyng Sher

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research|December 21, 2006
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasivenessYuh-Pyng Sher, Cheng-Chung Chou, Ruey-Hwang Chou, et al.
Biomed Research International|February 19, 2015
Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinomaChien-Ming Liu, Kuo-Liang Chiu, Tzu-Sheng Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivoShih-Hsin Tu, Hsing-I Huang, Su-I Lin, et al.
American Journal of Cancer Research|May 10, 2024
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progressionJing-Pei Liu, Kuan-Yin Shen, Wei-Chung Cheng, et al.
Journal of Leukocyte Biology|May 17, 2007
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6Shih-Jen Liu, Jy-Ping Tsai, Chia-Rui Shen, et al.
Oncotarget|May 25, 2017
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasisKuo-Liang Chiu, Yu-Sen Lin, Ting-Ting Kuo, et al.
Cancer Research|July 26, 2014
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayChen-Yuan Lin, Hung-Jen Chen, Cheng-Chung Huang, et al.
Molecular Oncology|April 4, 2023
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatmentSze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, et al.
Molecular Immunology|May 19, 2010
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptideChih-Hsiang Leng, Hsin-Wei Chen, Li-Sheng Chang, et al.
Molecular Therapy. Nucleic Acids|June 18, 2021
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinomaShu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research|December 21, 2006
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasivenessYuh-Pyng Sher, Cheng-Chung Chou, Ruey-Hwang Chou, et al.
Biomed Research International|February 19, 2015
Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinomaChien-Ming Liu, Kuo-Liang Chiu, Tzu-Sheng Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivoShih-Hsin Tu, Hsing-I Huang, Su-I Lin, et al.
American Journal of Cancer Research|May 10, 2024
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progressionJing-Pei Liu, Kuan-Yin Shen, Wei-Chung Cheng, et al.
Journal of Leukocyte Biology|May 17, 2007
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6Shih-Jen Liu, Jy-Ping Tsai, Chia-Rui Shen, et al.
Oncotarget|May 25, 2017
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasisKuo-Liang Chiu, Yu-Sen Lin, Ting-Ting Kuo, et al.
Cancer Research|July 26, 2014
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayChen-Yuan Lin, Hung-Jen Chen, Cheng-Chung Huang, et al.
Molecular Oncology|April 4, 2023
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatmentSze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, et al.
Molecular Immunology|May 19, 2010
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptideChih-Hsiang Leng, Hsin-Wei Chen, Li-Sheng Chang, et al.
Molecular Therapy. Nucleic Acids|June 18, 2021
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinomaShu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, et al.
Pageof 6